Vaishali Pharma Limited

NSE VAISHALI.NS

Vaishali Pharma Limited Total Non-Current Liabilities for the year ending March 31, 2024: USD 483.67 K

Vaishali Pharma Limited Total Non-Current Liabilities is USD 483.67 K for the year ending March 31, 2024, a -36.88% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
  • Vaishali Pharma Limited Total Non-Current Liabilities for the year ending March 31, 2023 was USD 766.30 K, a 74.58% change year over year.
  • Vaishali Pharma Limited Total Non-Current Liabilities for the year ending March 31, 2022 was USD 438.94 K, a -27.68% change year over year.
  • Vaishali Pharma Limited Total Non-Current Liabilities for the year ending March 31, 2021 was USD 606.95 K, a 3.79% change year over year.
  • Vaishali Pharma Limited Total Non-Current Liabilities for the year ending March 31, 2020 was USD 584.80 K, a -16.62% change year over year.
Key data
Date Total Non-Current Liabilities Shareholders' Equity Other Liabilities Total Liabilities
Market news
Loading...
SV Wall Street
NSE: VAISHALI.NS

Vaishali Pharma Limited

CEO Mr. Hemanth Damodar Pathak
IPO Date Aug. 22, 2017
Location India
Headquarters 706 to 709, Aravalli Business Center
Employees 27
Sector Healthcare
Industries
Description

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as antibiotics/antibacterial, anti-platelet, laxative, anti-ulcer/enzyme, anti-asthmatic, anti-malarial, anti-cold/anti-allergic/anti-viral, anti-psychotic, anti-fungal, anti-inflammatory/analgesic/anti-pyretic, anti-diabetic, cardiac, vitamins, topical steroids/corticosteroids, and other formulations. In addition, it offers veterinary pharmaceutical, nutraceutical, oncology, herbal, and surgical products. The company was founded in 1989 and is headquartered in Mumbai, India.

Similar companies

KREBSBIO.NS

Krebs Biochemicals & Industries Limited

USD 1.15

4.92%

ZOTA.NS

Zota Health Care Limited

USD 10.92

-0.24%

ALBERTDAVD.NS

Albert David Limited

USD 13.52

1.95%

BIOFILCHEM.NS

Biofil Chemicals and Pharmaceuticals Limited

USD 0.64

5.12%

StockViz Staff

February 2, 2025

Any question? Send us an email